Release Date: September 30, 2025
Expiration Date: September 30, 2026
Activity Overview
This educational activity is an archive of the live presentation held on September 7, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This activity is directed toward WCLC attendees, including an audience of oncologists, radiologists, pulmonologists, oncology RNs/PAs/NPs, and pharmacists involved in the treatment of NSCLC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Discuss current and emerging therapeutic options for first- and second-line treatment of EGFR-mutated NSCLC
- Formulate appropriate strategies for the management of adverse effects related to EGFR targeted therapies in NSCLC
- Develop individualized treatment plans for patients with EGFR-mutant NSCLC by implementing new data and guideline-recommended strategies

Tina Cascone, MD, PhD
Associate Professor
Physician-Scientist Director of Translational Research
Department of Thoracic/Head and Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX

Christina Baik, MD, MPH
Thoracic, Head and Neck Medical Oncology
Fred Hutchinson Cancer Center
University of Washington School of Medicine
Seattle, WA

David Planchard, MD, PhD
Head of Thoracic Group
Department of Medical Oncology
Institut Gustave Roussy
Villejuif, France
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here